Invicta Diagnostic Limited IPO
Invicta Diagnostic Limited IPO
Invicta Diagnostic Limited IPO
₹ 272000 / 3200 Shares Shares
Minimum Investment
Invicta Diagnostic Limited IPO
Issues Price
₹80-85 per equity share
Invicta Diagnostic Limited IPO
Open Date
01 Dec 2025
Close Date
03 Dec 2025
Lot Size
1600
Min. Investment
₹ 272000
Issue Price
₹80-85
Listing Date
08 Dec 2025
Issues Size
33,08,800 shares(aggregating up to ₹28.12 crore)
Face Value
₹10 Per Equity Share
Total Shares Offered
3200 Shares
Offered To Public
3200 Shares
Invicta Diagnostic Limited IPO
Incorporated in January 2021, Invicta Diagnostic Limited offers radiology and pathology solutions. It provides pathology and radiology testing comprising imaging, radiology, pathology, and teleradiology services under the brand 'PC Diagnostics” through 7 diagnostic centres and a central laboratory across Mumbai in Maharashtra. Invicta Diagnostics Limited, trading as PC Diagnostics, is a Mumbai-based diagnostic services company specializing in integrated pathology and radiology solutions. The company follows a hub‑and‑spoke model across the Mumbai Metropolitan Region, featuring: A flagship hub offering full-spectrum pathology and advanced radiology (CT, MRI) at Thane West Three other centres - Bhayandar, Byculla, Marol - offering specialized diagnostic services Basic imaging, including X-ray and ultrasound, and sample collection were the focus of spokes at Lower Parel, Sewri, Mazgaon, and Kalwa. It offers approximately 60 routine and 487 specialized pathology tests and around 96 basic and 130 advanced radiology investigations. Invicta Diagnostics provides a comprehensive suite of diagnostic services that includes: Routine Tests: Includes CBC, lipid profiles, liver function tests (LFT), kidney function tests (KFT), and thyroid panels Specialized Tests: Molecular diagnostics, immunoassays, infectious disease markers including dengue, COVID-19, cancer markers, and genetic panels. Sample Collection Network: Invicta uses phlebotomists and collection partners to reach patients at home or through its spoke centres. The company has a network of 5 laboratory doctors, 20 radiologists, and 127 well-trained technical staff as of May 31st, 2025. The company has 105 permanent employees as of May 31, 2025.
Founded In
2021
Managing Director
Dr. Ketan Jayantilal Jain
Parent Organization
Invicta Diagnostic Limited IPO
Application for Invicta Diagnostic Limited IPO
| Apply as | Price Range | Apply Upto |
|---|---|---|
| Individual (min) | ₹80-85 | ₹2,72,000 |
| Individual(max) | ₹80-85 | ₹2,72,000 |
| SHNI(min) | ₹80-85 | ₹4,08,000 |
| SHNI(max) | ₹80-85 | ₹9,52,000 |
| BHNI(min) | ₹80-85 | ₹10,88,000 |
Apply for all eligible candidates, Invicta Diagnostic Limited IPO.
Open On12 Dec 2025
Close On16 Dec 2025
Price Range₹2061-2165
Testimonial
Genuine Review Form Statisifed Customers
KSquare stands out with their personalized approach to NRI investing. Their team’s insights and professionalism are unmatched.
Very few services feel as reliable as KSquare’s NRI Corner. Their consistent communication and legal clarity made my decisions easier.
The way KSquare introduces New Fund Offerings is so clear and informative. I’ve been able to diversify with great timing and zero confusion.
Investing in NFOs through KSquare has been a game changer. Their platform simplifies complex information and provides well-timed suggestions that fit my portfolio.
I loved how simple KSquare made the entire loan procedure. No delays, no confusion—just straight financial help.
I never thought NPS could be this simple. KSquare gave me full control and transparency over my retirement planning.
Managing money in India while living overseas used to be stressful. KSquare’s platform made everything manageable and safe.
KSquare’s recommendations are on point. Their mutual fund picks are backed by solid research, and I’ve seen consistent returns over the past year.
Thanks to KSquare’s New Fund Offering alerts, I’ve been able to catch early opportunities that matched my long-term strategy and risk appetite.
KSquare’s NPS support was practical and transparent. They helped me compare options and choose what’s best for my future.
FAQ's
Frequenlty Asked Question
What types of mutual funds are available on KSquare?
KSquare offers equity, debt, hybrid, ELSS, and index funds to suit different financial goals and risk profiles.
Can I track my SIP performance on KSquare?
Yes, KSquare offers detailed tracking tools and insights so you can monitor your SIP performance anytime.
Do SIPs help in achieving children’s education goals?
Yes, SIPs offer structured savings and growth, ensuring funds are ready when needed for future school, college or career plans.
Can I invest jointly with a resident Indian through KSquare?
Yes, joint investments are allowed with a resident Indian, provided KYC and bank account norms are met.
Do NFOs offer better returns than existing funds?
Not always. While some NFOs may perform well, they lack historical data. KSquare helps evaluate the potential.
What is the National Pension System (NPS)?
NPS is a government-backed retirement savings scheme that lets you invest during your working life and withdraw upon retirement.
What are the tax benefits of NPS?
NPS offers deductions up to ₹1.5 lakh under Section 80C and an additional ₹50,000 under Section 80CCD(1B) of the Income Tax Act.
Is NPS better than PPF or EPF for retirement?
NPS can offer higher returns due to market exposure, while PPF and EPF are safer but lower-yielding. It’s best to diversify.